Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Constipation after starting Wegovy is common and often manageable with hydration, fiber, and gentle exercise. A practical checklist distinguishes routine symptoms—like fewer than three bowel movements per week and mild bloating—from red flags such as no movement for over 72 hours, severe abdominal pain, persistent nausea or vomiting, blood in the stool, or visible distension.
See below for the full checklist and detailed guidance on when to treat at home and when to seek medical attention.
Many people experience Wegovy constipation after starting therapy. Wegovy (semaglutide) is a GLP-1 receptor agonist approved for weight management. While it can help curb appetite and slow gastric emptying, this very effect can lead to constipation. In most cases, milder symptoms improve with simple measures—but you'll want to know when to treat at home and when to seek medical attention.
Wegovy works by:
These actions can lead to firmer stools, less frequent bowel movements, and a feeling of blockage. Symptoms often appear in the first few weeks as your body adjusts, then stabilize or improve over time.
Use the following checklist to gauge whether your Wegovy-related constipation is mild or warrants medical evaluation:
If you notice any red-flag symptoms, take them seriously. They could indicate a bowel obstruction, impaction, or a separate digestive issue requiring prompt attention.
Most cases of mild to moderate Wegovy constipation can be managed at home. Try these evidence-backed tips:
Always start with the lowest effective dose. If you're unsure which product suits you best, consult a pharmacist.
While mild discomfort often resolves, persistent or severe issues require professional evaluation. Contact your healthcare provider or speak to a doctor if you experience:
If any symptom feels life threatening—sudden severe pain, persistent vomiting, confusion, rapid heartbeat—head to the nearest emergency department.
If you're experiencing persistent digestive issues and want to better understand your symptoms, try Ubie's free AI-powered Constipation symptom checker to help determine whether your condition requires immediate medical attention or can be managed at home.
Once you've gotten through the initial adjustment period, sustain healthy habits to minimize recurrence:
Wegovy constipation after starting therapy is common and often temporary. Use the checklist to distinguish mild symptoms from red flags, implement lifestyle and OTC measures, and seek help if severe or prolonged issues arise. Remember, prompt action can prevent complications.
If you have any serious concerns—or if constipation is accompanied by severe pain, vomiting, or other alarming signs—please speak to a doctor right away. Your health and peace of mind are worth it.
(References)
* Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185.
* Singh G, D'Souza D, Kumar S, et al. Adverse Events Associated With Semaglutide: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 May 2;5(5):e2213710. doi: 10.1001/jamanetworkopen.2022.13710. PMID: 35503460; PMCID: PMC9065969.
* Chang L, Chey WD, Lembo AJ, et al. A review of the effects of glucagon-like peptide-1 receptor agonists on gastrointestinal motility and their potential relevance to gastrointestinal symptoms. Neurogastroenterol Motil. 2021 Jul;33(7):e14088. doi: 10.1111/nmo.14088. Epub 2021 Mar 22. PMID: 33754298.
* Früh M, Baumgartner H, Kaser S, et al. Real-world safety and tolerability of semaglutide and dulaglutide for type 2 diabetes management: a pooled analysis. Diabetes Res Clin Pract. 2023 Apr;200:110706. doi: 10.1016/j.diabres.2023.110706. Epub 2023 Feb 28. PMID: 36863489.
* Mishra R, Kumar A, Kumar P, Singh V, Agrawal S. Gastrointestinal Adverse Events Associated With Semaglutide: A Systematic Review. J Clin Pharmacol. 2024 Jan;64(1):23-32. doi: 10.1002/jcph.2343. Epub 2023 Oct 12. PMID: 37827917.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.